Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Clin Vaccine Immunol. 2012 Apr;19(4):623-5. doi: 10.1128/CVI.05705-11. Epub 2012 Feb 29.

Tick-borne encephalitis virus-neutralizing antibodies in different immunoglobulin preparations.

Author information

  • 1Global Pathogen Safety, Baxter BioScience, Vienna, Austria.

Abstract

Patients with primary immunodeficiency (PIDs) depend on the presence of a variety of antibody specificities in intravenous immunoglobulin (IVIG). Using the tick-borne encephalitis virus (TBEV), geographic variability in IVIG antibody content was shown. Care should therefore be exercised when treating PIDs in a given geography, as only locally sourced plasma contains the antibody specificities against the circulating pathogens in the given locality.

PMID:
22379062
[PubMed - indexed for MEDLINE]
PMCID:
PMC3318267
Free PMC Article

Images from this publication.See all images (1)Free text

Fig 1
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk